1-2 of 2
Authors: Madiha Iqbal
Sort by
Journal Article
CTIM-34. PRELIMINARY SAFETY AND EFFICACY DATA ON TWO PATIENTS WITH RELAPSED/REFRACTORY CNS LYMPHOMA TREATED WITH EMAVUSERTIB (CA-4948) AND IBRUTINIB COMBINATION: A SUBSET ANALYSIS OF TAKEAIM LYMPHOMA TRIAL Free
Madiha Iqbal and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii68–vii69, https://doi.org/10.1093/neuonc/noac209.266
Published: 14 November 2022
Journal Article
EXTH-93. THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA Free
Christina von Roemeling and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii231, https://doi.org/10.1093/neuonc/noac209.891
Published: 14 November 2022
Advertisement
Advertisement